Dental management of patients receiving oral bisphosphonate therapy
- 1 August 2006
- journal article
- Published by Elsevier BV in The Journal of the American Dental Association
- Vol. 137 (8), 1144-1150
- https://doi.org/10.14219/jada.archive.2006.0355
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Practical Guidelines for the Prevention, Diagnosis, and Treatment of Osteonecrosis of the Jaw in Patients With CancerJournal of Oncology Practice, 2006
- Jaw osteonecrosis associated with bisphosphonates: Multiple exposed areas and its relationship to teeth extractions. Study of 20 casesOral Oncology, 2005
- Bisphosphonate-Induced Exposed Bone (Osteonecrosis/Osteopetrosis) of the Jaws: Risk Factors, Recognition, Prevention, and TreatmentJournal of Oral and Maxillofacial Surgery, 2005
- Bisphosphonate‐associated osteonecrosis of mandibular and maxillary boneCancer, 2005
- Severely Suppressed Bone Turnover: A Potential Complication of Alendronate TherapyJournal of Clinical Endocrinology & Metabolism, 2005
- Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 casesJournal of Oral and Maxillofacial Surgery, 2004
- Bisphosphanates and Oral Cavity Avascular Bone NecrosisJournal of Clinical Oncology, 2003
- Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemicJournal of Oral and Maxillofacial Surgery, 2003
- Administration routes and delivery systems of bisphosphonates for the treatment of bone resorptionAdvanced Drug Delivery Reviews, 2000
- Pharmacokinetics of Pamidronate Disodium in Patients with Cancer with Normal or Impaired Renal FunctionThe Journal of Clinical Pharmacology, 1997